SARA KOOTMAN: Open Payments
NPI 1710686894 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 31 payments from 6 companies in 2025. Trend: 2023 $777 · 2024 $2,255 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $408 |
| Amneal Pharmaceuticals LLC | 2 | $54 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| PFIZER INC. | 2 | $30 |
| SK Life Science, Inc. | 1 | $26 |
| Grifols USA, LLC | 1 | $23 |
Products named: QULIPTA, BOTOX, UBRELVY, VYALEV, CREXONT, Symbravo, NURTEC ODT, Gamunex-C.
Industry payments across MO — which companies pay providers there.
